Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Bengu N, Cromhout G, Adland E, Govender K, Herbert N, Lim N, Fillis R, Sprenger K, Vieira V, Kannie S, van Lobenstein J, Chinniah K, Kapongo C, Bhoola R, Krishna M, Mchunu N, Pascucci GR, Cotugno N, Palma P, Tagarro A, Rojo P, Roider J, Garcia-Guerrero MC, Ochsenbauer C, Groll A, Reddy K, Giaquinto C, Rossi P, Hong S, Dong K, Ansari MA, Puertas MC, Ndung'u T, Capparelli E, Lichterfeld M, Martinez-Picado J, Kappes JC, Archary M, Goulder P. Bengu N, et al. Among authors: giaquinto c. Nat Med. 2024 Oct;30(10):2796-2804. doi: 10.1038/s41591-024-03105-4. Epub 2024 Jun 6. Nat Med. 2024. PMID: 38843818 Free PMC article.
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile.
Nguyen AN, Plotkin AL, Odumade OA, De Armas L, Pahwa S, Morrocchi E, Cotugno N, Rossi P, Foster C, Domínguez-Rodríguez S, Tagarro A, Syphurs C, Diray-Arce J, Fatou B, Ozonoff A, Levy O, Palma P, Smolen KK; on the behalf of the EPIICAL Consortium. Nguyen AN, et al. Pediatr Res. 2023 Nov;94(5):1667-1674. doi: 10.1038/s41390-023-02669-0. Epub 2023 Jun 13. Pediatr Res. 2023. PMID: 37308683
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium.
Kuhn L, Barnabas S, Cotugno N, Peay H, Goulder P, Cotton M, Violari A, Pahwa S, Reddy K, Tagarro A, Otwombe K, Fry S, Vaz P, Lain MG, Nhampossa T, Archary M, Maiga AI, Puthanakit T, Kityo CM, Foster C, Rojo P, Klein N, Nastouli E, Tiemessen CT, de Rossi A, Ndung'u T, Persaud D, Lichterfeld M, Giaquinto C, Palma P, Rossi P; EPIICAL consortium. Kuhn L, et al. Among authors: giaquinto c. Lancet HIV. 2024 Oct;11(10):e700-e710. doi: 10.1016/S2352-3018(24)00157-7. Epub 2024 Jul 23. Lancet HIV. 2024. PMID: 39059402 Review.
HIV reservoir and premature aging: risk factors for aging-associated illnesses in adolescents and young adults with perinatally acquired HIV.
Petrara MR, Ruffoni E, Carmona F, Cavallari I, Zampieri S, Morello M, Del Bianco P, Rampon O, Cotugno N, Palma P, Rossi P, Giaquinto C, Giunco S, De Rossi A. Petrara MR, et al. Among authors: giaquinto c. PLoS Pathog. 2024 Sep 23;20(9):e1012547. doi: 10.1371/journal.ppat.1012547. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39312589 Free PMC article.
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries.
Tagarro A, Domínguez-Rodríguez S, Cotton M, Otwombe K, Klein N, Lain MG, Nhampossa T, Maiga AI, Barnabas S, Vaz P, Violari A, Fernández-Luis S, Behuhuma O, Sylla M, López-Varela E, Naniche D, Janse-Van-Rensburg A, Liberty A, Ramsagar N, Smit T, Makhari S, Ismael N, Giaquinto C, Rossi P, Kuhn L, Palma P, Spyer M, Lichterfeld M, Nastuoli E, Giannuzzi V, Ballesteros A, Cotugno N, Morrocchi E, Oletto A, Traoré FT, Dobbels E, Akhalwaya Y, Ording-Jespersen G, Foster C, Rabie H, Amuge P, Brehin C, Pahwa S, Coulibaly YA, Rojo P; EPIICAL Consortium. Tagarro A, et al. Among authors: giaquinto c. EClinicalMedicine. 2024 May 23;73:102648. doi: 10.1016/j.eclinm.2024.102648. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 39411486 Free PMC article.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM, Ford D; ODYSSEY trial team. Turkova A, et al. Among authors: giaquinto c. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727. doi: 10.1016/S2352-4642(23)00164-5. Epub 2023 Aug 8. Lancet Child Adolesc Health. 2023. PMID: 37562418 Free PMC article. Clinical Trial.
COVID-19 and MIS-C treatment in children-results from an international survey.
Donà D, Minotti C, Masini T, Penazzato M, Van Der Zalm MM, Judd A, Giaquinto C, Lallemant M; Survey Respondents Consortium. Donà D, et al. Among authors: giaquinto c. Eur J Pediatr. 2023 Nov;182(11):5087-5093. doi: 10.1007/s00431-023-05179-7. Epub 2023 Sep 6. Eur J Pediatr. 2023. PMID: 37672062 Free PMC article.
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.
Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C, Ford D; D3 trial team. Turkova A, et al. Among authors: giaquinto c. Contemp Clin Trials. 2024 Jul;142:107540. doi: 10.1016/j.cct.2024.107540. Epub 2024 Apr 16. Contemp Clin Trials. 2024. PMID: 38636725 Free article. Clinical Trial.
Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study.
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Kakuda TN, Nijs S, Tambuyzer L, Tomaka FL; PIANO study group. Tudor-Williams G, et al. HIV Med. 2014 Oct;15(9):513-24. doi: 10.1111/hiv.12141. Epub 2014 Mar 3. HIV Med. 2014. PMID: 24589294 Free article. Clinical Trial.
548 results